Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 18, 2020
Arctoris has signed a Memorandum of Understanding with listed Korean company Syntekabio to collaborate on drug discovery efforts.
read more
Arcturus and Catalent have announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate intended to protect against the SARS-CoV-2 coronavirus.
read more
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, has announced that Paul Korner, MD, MBA, joined the Company in a newly created position as Executive Vice President and Chief Medical ...
read more
Tuesday, November 28, 2017
Ardelyx and Kyowa Hakko Kirin announced they have entered into a license agreement that provides Kyowa Hakko Kirin with exclusive rights to develop and commercialize tenapanor.
read more
Ardena has acquired ChemConnection, a contract manufacturer of novel APIs and nanomedicines.
read more
Wednesday, September 08, 2021
Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), has announced that it has acquired Idifarma, a leading Contract Manufacturer of niche and highly potent generic and innovative drugs.
read more
Ardena has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.
read more
Contract development manufacturer of nanomedicines, Ardena, has joined forces with mRNA and LNP technology specialists RiboPro to form a new strategic commercial alliance aimed at delivering improvements
read more
Thursday, October 20, 2022
Ardena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning across the development life cycle, is investing into almost trebling the size of its Swedish facility as part ...
read more
Thursday, November 06, 2025
Ardena announced the appointment of Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer. These appointments strengthen Ardena’s executive leadership team and reflect its continued focus on quality, compliance, and ...
read more
Ardena announced the appointment of Paul Edwards as Chief People Officer. He will lead Ardena’s global people strategy, strengthening organizational capability and supporting the company’s continued international growth.
read more
Tuesday, February 04, 2025
Ardena announced that it has successfully completed the acquisition of Catalent’s state-of-the-art drug product manufacturing facility in Somerset, New Jersey.
read more
Thursday, January 29, 2026
Ardena announced that it has completed the divestment of its drug substance (API) site in Södertälje, Sweden, to Nanologica AB.
read more
Ardena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning all the development life cycle, has announced upgrades to its development and manufacturing facilities in ...
read more
Tuesday, October 29, 2024
Ardena announced a substantial expansion of its Bioanalytical Services in the Netherlands. This strategic investment includes establishing a brand new bioanalytical lab at Ardena’s Pivot Park facility in Oss, along with additional capacity and new ...
read more